REVERAGEN BIOPHARMA INC has a total of 34 patent applications. It decreased the IP activity by 66.0%. Its first patent ever was published in 2009. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and environmental technology are TELOMERASE ACTIVATION SCIENCES INC, KENNETH S WARREN INST and PACIFIC ARROW LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 11 | |
#2 | Australia | 5 | |
#3 | EPO (European Patent Office) | 5 | |
#4 | Hungary | 3 | |
#5 | WIPO (World Intellectual Property Organization) | 3 | |
#6 | Japan | 2 | |
#7 | Republic of Korea | 2 | |
#8 | Brazil | 1 | |
#9 | Canada | 1 | |
#10 | China | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Environmental technology | |
#4 | Machines | |
#5 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Steroids | |
#4 | Climate change adaptation technologies | |
#5 | Unspecified technologies | |
#6 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Hoffman Eric | 30 |
#2 | Mccall John M | 28 |
#3 | Damsker Jesse | 13 |
#4 | Kanneboyina Nagaraju | 13 |
#5 | Nagaraju Kanneboyina | 11 |
#6 | Kanneboyina Raju | 7 |
#7 | John M Mccall | 3 |
#8 | Eric Hoffman | 3 |
#9 | Mccall John | 2 |
#10 | Fiorillo Alyson | 1 |
Publication | Filing date | Title |
---|---|---|
US2020281942A1 | Aqueous oral pharmaceutical suspension compositions | |
WO2017004205A1 | NON-HORMONAL STEROID MODULATORS OF NF-κB FOR TREATMENT OF DISEASE | |
WO2014169126A1 | Methods and agents to increase therapeutic dystrophin expression in muscle | |
WO2013082253A2 | Non-hormonal steroid modulators of nf-kb for treatment of disease |